| # | Title | Journal | Year | Citations |
|---|
| 1 | High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners | Fertility and Sterility | 2009 | 445 |
| 2 | ISUOG Practice Guidelines: role of ultrasound in twin pregnancy | Ultrasound in Obstetrics and Gynecology | 2016 | 445 |
| 3 | The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey | Human Reproduction | 2013 | 330 |
| 4 | Surgical treatment of deeply infiltrating endometriosis with colorectal involvement | Human Reproduction Update | 2011 | 278 |
| 5 | Endometrial Thickness Measurement for Detecting Endometrial Cancer in Women With Postmenopausal Bleeding | Obstetrics and Gynecology | 2010 | 251 |
| 6 | Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver variability and experience | Ultrasound in Obstetrics and Gynecology | 1999 | 216 |
| 7 | Management of Borderline Ovarian Neoplasms | Journal of Clinical Oncology | 2007 | 174 |
| 8 | ISUOG Practice Guidelines: performance of fetal magnetic resonance imaging | Ultrasound in Obstetrics and Gynecology | 2017 | 153 |
| 9 | A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: The development of a new logistic regression model | American Journal of Obstetrics and Gynecology | 1999 | 149 |
| 10 | Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer | Gynecologic Oncology | 2005 | 142 |
| 11 | Genome-wide association study identifies a common variant associated with risk of endometrial cancer | Nature Genetics | 2011 | 141 |
| 12 | Safety and dose modification for patients receiving niraparib | Annals of Oncology | 2018 | 125 |
| 13 | A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45) | Journal of Clinical Oncology | 2022 | 125 |
| 14 | Assessment of fetal cardiac function before and after therapy for twin-to-twin transfusion syndrome | American Journal of Obstetrics and Gynecology | 2009 | 119 |
| 15 | Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses | Ultrasound in Obstetrics and Gynecology | 1999 | 112 |
| 16 | Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium | British Journal of Cancer | 2015 | 111 |
| 17 | Sarcopenia and ovarian cancer survival: a systematic review and meta‐analysis | Journal of Cachexia, Sarcopenia and Muscle | 2019 | 108 |
| 18 | Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree? | Gynecologic Oncology | 2013 | 105 |
| 19 | An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib | Targeted Oncology | 2016 | 103 |
| 20 | Meigs’ Syndrome with Elevated Serum CA 125 Levels: Two Case Reports and Review of the Literature | Gynecologic Oncology | 1995 | 98 |
| 21 | Prospective Internal Validation of Mathematical Models to Predict Malignancy in Adnexal Masses: Results from the International Ovarian Tumor Analysis Study | Clinical Cancer Research | 2009 | 97 |
| 22 | Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature | International Journal of Gynecological Cancer | 2006 | 93 |
| 23 | Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome | American Journal of Obstetrics and Gynecology | 2007 | 87 |
| 24 | Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2 | Gynecologic Oncology | 2016 | 81 |
| 25 | Maternal outcomes and risk factors for COVID-19 severity among pregnant women | Scientific Reports | 2021 | 77 |
| 26 | Outcome after multidisciplinary CO2 laser laparoscopic excision of deep infiltrating colorectal endometriosis | Reproductive BioMedicine Online | 2009 | 76 |
| 27 | Validation of the fetal myocardial performance index in the second and third trimesters of gestation | Ultrasound in Obstetrics and Gynecology | 2009 | 74 |
| 28 | Robotic retroperitoneal lower para‐aortic lymphadenectomy in cervical carcinoma: First report on the technique used in 5 patients | Acta Obstetricia Et Gynecologica Scandinavica | 2008 | 70 |
| 29 | Left ventricular cardiac function in fetuses with congenital diaphragmatic hernia and the effect of fetal endoscopic tracheal occlusion | Ultrasound in Obstetrics and Gynecology | 2009 | 69 |
| 30 | Congenital cytomegalovirus infection: contribution and best timing of prenatal MR imaging | European Radiology | 2016 | 67 |
| 31 | Twin-to-twin transfusion syndrome (TTTS)* | Journal of Perinatal Medicine | 2011 | 64 |
| 32 | Management of cancer in pregnancy | Best Practice and Research in Clinical Obstetrics and Gynaecology | 2015 | 63 |
| 33 | Ultrasound characteristics of endometrial cancer as defined by International Endometrial Tumor Analysis (IETA) consensus nomenclature: prospective multicenter study | Ultrasound in Obstetrics and Gynecology | 2018 | 61 |
| 34 | Determination of the Full Dose–Response Relation of Intrathecal Bupivacaine, Levobupivacaine, and Ropivacaine, Combined with Sufentanil, for Labor Analgesia | Anesthesiology | 2007 | 60 |
| 35 | Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel | Annals of Oncology | 2014 | 60 |
| 36 | Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial | Gynecologic Oncology | 2011 | 59 |
| 37 | Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma | Gynecologic Oncology | 2004 | 58 |
| 38 | Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer | Annals of Oncology | 2016 | 58 |
| 39 | Using literature and data to learn Bayesian networks as clinical models of ovarian tumors | Artificial Intelligence in Medicine | 2004 | 57 |
| 40 | Pseudo-Meigs' Syndrome Caused by a Hydropic Degenerating Uterine Leiomyoma with Elevated CA 125 | Gynecologic Oncology | 2001 | 55 |
| 41 | Mutations inCEP120cause Joubert syndrome as well as complex ciliopathy phenotypes | Journal of Medical Genetics | 2016 | 55 |
| 42 | Managing pregnancy of unknown location based on initial serum progesterone and serial serum hCG levels: development and validation of a two‐step triage protocol | Ultrasound in Obstetrics and Gynecology | 2016 | 54 |
| 43 | The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment | Gynecologic Oncology | 2010 | 53 |
| 44 | Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients – A study of the OVCAD consortium | European Journal of Cancer | 2014 | 53 |
| 45 | The Use of a New Gel Foam for the Evaluation of Tubal Patency | Gynecologic and Obstetric Investigation | 2013 | 52 |
| 46 | Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies | Gynecologic Oncology | 2015 | 52 |
| 47 | Amniotic fluid markers of fetal cardiac dysfunction in twin-to-twin transfusion syndrome | American Journal of Obstetrics and Gynecology | 2010 | 51 |
| 48 | Ovarian cancer arising in endometrioid cysts: ultrasound findings | Ultrasound in Obstetrics and Gynecology | 2011 | 51 |
| 49 | Cancer in pregnancy: a survey of current clinical practice | European Journal of Obstetrics, Gynecology and Reproductive Biology | 2013 | 51 |
| 50 | Reduced adaptation of the pancreatic B cells during pregnancy is the major causal factor for gestational diabetes: Current knowledge and metabolic effects on the offspring | Acta Obstetricia Et Gynecologica Scandinavica | 2008 | 50 |
